Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.16)
# 1,582
Out of 5,136 analysts
887
Total ratings
37.9%
Success rate
6.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | $60 | $57.99 | +3.47% | 18 | Nov 16, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | $80 | $40.37 | +98.17% | 23 | Nov 16, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $45 | $22.50 | +100.04% | 6 | Nov 16, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $70 | $28.01 | +149.91% | 39 | Nov 16, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $5 | $1.64 | +204.88% | 30 | Nov 16, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $65 | $15.99 | +306.50% | 71 | Nov 16, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $11.82 | - | 46 | Nov 16, 2026 | |
| ALMS Alumis | Rated: Buy | $15 → $9 | $5.14 | +75.10% | 27 | Nov 13, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $344 → $335 | $271.73 | +23.28% | 7 | Nov 13, 2026 | |
| CBIO Crescent Biopharma | Reiterated: Buy | $36 → $40 | $13.50 | +196.30% | 14 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.10 | - | 13 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $10.49 | +185.99% | 9 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.76 | +425.21% | 25 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $39 | $14.65 | +166.21% | 29 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.74 | +128.83% | 6 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $9.86 | +153.55% | 19 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.43 | +211.04% | 4 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $15.37 | +290.37% | 3 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $90 | $53.12 | +69.43% | 1 | Nov 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $5 | $1.03 | +385.44% | 10 | Nov 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $27 | $19.74 | +36.78% | 40 | Nov 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.87 | +167.38% | 11 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $60 | $23.30 | +157.51% | 37 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $99.24 | +20.92% | 22 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.37 | - | 11 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $9.16 | +172.93% | 3 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $96.50 | +34.72% | 66 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $12.71 | +18.02% | 27 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $6.08 | +311.18% | 26 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $15.13 | -66.95% | 39 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $152 | $120.27 | +26.38% | 27 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 600.00 | kr 480.20 | +24.95% | 11 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $11 | $1.99 | +454.16% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $3.23 | +209.60% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.75 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.41 | n/a | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.68 | n/a | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $1.08 | n/a | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.39 | n/a | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.43 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.5403 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.60 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $2.75 | n/a | 6 | May 14, 2024 |
BioMarin Pharmaceutical
Nov 16, 2026
Reiterated: Hold
Price Target: $60
Current: $57.99
Upside: +3.47%
CRISPR Therapeutics AG
Nov 16, 2026
Reiterated: Buy
Price Target: $80
Current: $40.37
Upside: +98.17%
Damora Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $45
Current: $22.50
Upside: +100.04%
Ionis Pharmaceuticals
Nov 16, 2026
Reiterated: Buy
Price Target: $70
Current: $28.01
Upside: +149.91%
Century Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $5
Current: $1.64
Upside: +204.88%
Legend Biotech
Nov 16, 2026
Reiterated: Buy
Price Target: $65
Current: $15.99
Upside: +306.50%
Summit Therapeutics
Nov 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.82
Upside: -
Alumis
Nov 13, 2026
Rated: Buy
Price Target: $15 → $9
Current: $5.14
Upside: +75.10%
Ascendis Pharma
Nov 13, 2026
Reiterated: Buy
Price Target: $344 → $335
Current: $271.73
Upside: +23.28%
Crescent Biopharma
Nov 13, 2026
Reiterated: Buy
Price Target: $36 → $40
Current: $13.50
Upside: +196.30%
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.10
Upside: -
Nov 13, 2026
Reiterated: Buy
Price Target: $30
Current: $10.49
Upside: +185.99%
Nov 13, 2026
Reiterated: Buy
Price Target: $25
Current: $4.76
Upside: +425.21%
Nov 13, 2026
Reiterated: Buy
Price Target: $45 → $39
Current: $14.65
Upside: +166.21%
Nov 13, 2026
Reiterated: Buy
Price Target: $20
Current: $8.74
Upside: +128.83%
Nov 13, 2026
Reiterated: Buy
Price Target: $25
Current: $9.86
Upside: +153.55%
Nov 13, 2026
Reiterated: Buy
Price Target: $20
Current: $6.43
Upside: +211.04%
Nov 13, 2026
Reiterated: Buy
Price Target: $60
Current: $15.37
Upside: +290.37%
Nov 12, 2026
Initiated Coverage: Buy
Price Target: $90
Current: $53.12
Upside: +69.43%
Nov 11, 2026
Reiterated: Buy
Price Target: $7 → $5
Current: $1.03
Upside: +385.44%
Nov 11, 2026
Reiterated: Buy
Price Target: $29 → $27
Current: $19.74
Upside: +36.78%
Nov 10, 2026
Reiterated: Buy
Price Target: $5
Current: $1.87
Upside: +167.38%
Nov 10, 2026
Reiterated: Buy
Price Target: $65 → $60
Current: $23.30
Upside: +157.51%
Nov 10, 2026
Reiterated: Buy
Price Target: $120
Current: $99.24
Upside: +20.92%
Nov 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.37
Upside: -
Nov 6, 2026
Reiterated: Buy
Price Target: $25
Current: $9.16
Upside: +172.93%
Nov 6, 2026
Reiterated: Buy
Price Target: $130
Current: $96.50
Upside: +34.72%
Nov 6, 2026
Reiterated: Buy
Price Target: $15
Current: $12.71
Upside: +18.02%
Nov 6, 2026
Reiterated: Buy
Price Target: $25
Current: $6.08
Upside: +311.18%
Nov 6, 2026
Reiterated: Sell
Price Target: $5
Current: $15.13
Upside: -66.95%
Nov 5, 2026
Reiterated: Buy
Price Target: $152
Current: $120.27
Upside: +26.38%
Nov 2, 2026
Reiterated: Buy
Price Target: kr 600.00
Current: kr 480.20
Upside: +24.95%
May 11, 2026
Reiterated: Buy
Price Target: $17 → $11
Current: $1.99
Upside: +454.16%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $3.23
Upside: +209.60%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $5.75
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $2.41
Upside: n/a
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $0.68
Upside: n/a
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $1.08
Upside: n/a
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $4.39
Upside: n/a
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $15.43
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.5403
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $2.60
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $2.75
Upside: n/a